Please login to the form below
Covid-19
This page shows the latest Covid-19 news and features for those working in and with pharma, biotech and healthcare.
Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients
The first exploratory analysis of 400 evaluable participants found that passive vaccination with REGEN-COV resulted in 100% prevention of symptomatic COVID-19 infections. ... patients aged at least 12 years old who weigh at least 40kg and are at high
Latest news
-
Merck ends its COVID-19 vaccine programme after disappointing early trial results
Merck &Co (MSD) has ended its COVID-19 vaccine programme after reviewing some disappointing phase 1 results for its candidates V590 and V591. ... On a more positive note, Merck will continue to advance clinical programmes for two novel therapeutics
-
Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
Moderna has announced that its COVID-19 vaccine appears effective against new coronavirus variants discovered in the UK and South Africa (SA). ... Vaccine developers, as well as COVID-19 drugmakers, have been rushing to test their respective candidates
-
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
up. There was also no evidence that azithromycin reduced COVID-19-associated hospitalisations or death compared with standard care. ... Doctors across the country had been using the drugs to target COVID-19 when it is in its early stages.
-
AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
AstraZeneca (AZ) has hit back at German media reports suggesting that its Oxford University-partnered COVID-19 vaccine is less effective in people over the age of 65. ... Here we found similar safety and immunogenicity of ChAdOx1 nCoV-19 in older adults
-
A happier new year?
It is also important to recognise that, sadly, some readers spent Christmas 2020 without a loved one due to COVID-19, and my thoughts are very much with you and your ... Even after the year we have had, there is still a lot to be positive and excited
More from news
Approximately 310 fully matching, plus 65 partially matching documents found.
Latest Intelligence
-
An EU emergency health fund to limit the impact of future crises
The COVID-19 pandemic, and the necessary restrictions and regulations brought in around the world to curb the spread of the virus, has resulted in a global economic crisis. ... risks. The ongoing and unprecedented public health crisis caused by COVID-19
-
The pandemic preparedness paradox
We must act now. It would be easier to start this work after COVID-19, after we all have our feet under us once again. ... control of COVID-19, the next emergency will draw all attention and sap the collective will.
-
The search for effective drug treatments for COVID-19
a 10-day dosing regimen of remdesivir administered intravenously versus standard of care in patients with moderate manifestations of COVID-19. ... The European Commission has signed a joint procurement agreement for Gilead’s COVID-19 antiviral
-
2021: the year of decentralisation in drug development
Rising costs and timelines to bring innovative therapies to market – not to mention the COVID-19 pandemic – have accelerated the surge in demand for decentralised clinical trials. ... Adopt agile remote monitoring to keep trials on track. During COVID
-
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
In the context of COVID-19, when healthcare systems are strained and we try to protect those with underlying conditions from the direct and indirect impact of the virus, the need
More from intelligence
Approximately 8 fully matching, plus 66 partially matching documents found.
Latest from PMHub
-
Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
Join Natalie Yeadon for our upcoming Fireside Chat where we will explore the importance of health literacy, patient voices, and workforce wellbeing during COVID-19 with and .
-
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. ... But with COVID-19 putting clinical trials to the forefront of people’s attention, we wanted to see how this had impacted awareness and the
-
The heavy toll of COVID-19 on cancer patients
During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. ... Several regulations surrounding clinical trials have been loosened during COVID-19, particularly in the US.
-
Mistrust in medical research: a patient perspective
The Thalidomide Society has said that comparisons between thalidomide and the COVID-19 vaccine are “insulting”. ... The Royal Society of Medicine has been running a series of COVID-19 webinars.
-
3 reasons why clinical trials will thrive in 2021
This is likely due to their increased susceptibility to COVID-19, and that online appointments enabled them to continue shielding from the safety of their homes. ... COVID-19 has impacted our lives in a whole host of ways, but has left us with a shared,
More from PMHub
Approximately 62 fully matching, plus 125 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- Pfizer/BioNTech reach vaccine supply agreement with COVAX
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients
- Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
- Merck ends its COVID-19 vaccine programme after disappointing early trial results
- Wilmington Healthcare appoints new Head of Digital
PMHub
claire@dovetailstrategies.com
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...
Latest intelligence
- An EU emergency health fund to limit the impact of future crises
- Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
Quick links
Infographics
